Skip to content


Dr. Jeffrey Graves

Dr. Jeffrey Graves

President and CEO

3D Systems

Dr. Jeffrey Graves is President and CEO of 3D Systems, and a member of the Board. He joined the company in May 2020.

Prior to joining 3D Systems, from 2012 to May 2020, Dr. Graves served as CEO, President and Director of MTS Systems Corporation, a global supplier of test, simulation, and measurement systems. From 2005 to 2012, he served as President, CEO and Director of C&D Technologies, Inc., an energy storage company. He also held several leadership roles with Kemet Corporation including Chief Operating Officer (2001-2003) and President, CEO and Director (2003-2005). Dr. Graves began his career at Rockwell International, and later held positions of increasing responsibility at General Electric Company.

In addition to his extensive tenure as a public company CEO, Dr. Graves has over 30 years of experience as an independent Board of Directors Member with Teleflex Corporation (2007-2017), Hexcel Corporation (2007-2024), and Integra Life Sciences Corporation (2023-present).

Dr. Graves holds a bachelor’s degree in metallurgical engineering from Purdue University, as well as a master’s degree and PhD in metallurgical engineering from the University of Wisconsin. He has been recognized with the Distinguished Alumni Award from both universities. Dr. Graves is also a master black belt in six sigma.


3D Systems logo

Delivering Leading Additive Manufacturing Solutions and Expertise to Advance Applications and Industries

3D Systems launched the 3D printing industry in 1986 and has been leading additive manufacturing innovation ever since. Our broad portfolio of hardware, software, and material solutions spans from plastics to metals, and is backed by industry-specific engineering expertise housed in our Applications Innovation Group. We take a consultative, application-focused approach to solving your most difficult design and production challenges.

The combination of our solutions, expertise, and innovation helps our users defy conventional manufacturing limitations and maximize the value of additive manufacturing. Headquartered in Rock Hill, South Carolina, with offices, manufacturing facilities, and Customer Innovation Centers around the globe, 3D Systems has the expertise and resources to advance industries.

Stay current with our latest news and the transformative impacts of our solutions on design and manufacturing workflows and outcomes. Read about 3D Systems in the news.


3D Systems at RAPID + TCT 2024
Booth 2401

3D Systems is the originator of 3D printing and an innovator of future 3D solutions. It has spent its 30-year history enabling professionals and companies to optimize their designs, transform their workflows, bring groundbreaking products to market and drive new business models. This is achieved with the Company’s best of breed digital manufacturing ecosystem. It’s comprised of plastic and metal 3D printers, print materials, consulting services and end-to-end manufacturing software solutions. Combinations of these products and services address a variety of advanced applications- ranging from Aerospace, Automotive, Semiconductor and Jewelry to Medical, Dental, and Bioprinting. For example, 3D Systems’ precision healthcare capabilities include simulation, Virtual Surgical Planning, and printing of medical and dental devices as well as patient-specific surgical instruments. More information on the company is available at

Join 3D Systems, on the Main Stage for the Executive Perspective Keynote Series Panel

Tuesday, June 25, 2024

8:30 AM | SME Main Stage
Keynote Series Executive Perspective
Dr. Jeffrey Graves, President and CEO, 3D Systems

Gain unparalleled access to the minds shaping the global additive manufacturing landscape. Join us each morning as we kick off RAPID + TCT with our inaugural Executive Perspectives Panel discussions. Meet industry luminaries each day as they tackle your biggest AM questions. Hear about innovative trends, industry evolution along with the greatest opportunities and challenges for the future of AM. Don’t miss these must-attend inspiring talks.

See 3D Systems on the RAPID + TCT Conference Stage and Tech Hub

Tuesday, June 25, 2024

11:00 AM | Conference Room 406 A
Rekindling Artistry in the Automotive Aftermarket Through Additive Manufacturing
Primary Presenter: Dmitriy Orlov, CTO, BBI Autosport
Co-Presenter: Joe Dopkowski, Senior Applications Engineer, 3D Systems

Founded in the Summer of 2005, BBI Autosport’s mission is to return artistry and craft to the exotic tuning market. With decades of professional racing history fueling the engineering and development of performance parts and services, BBI has quickly become a household name in the Porsche motorsports industry.

BBI is currently embarking on a journey to produce boutique street and race cars that are a significant step above the rest in terms of quality, and technological prowess. Driven by their spirit of innovation, BBI has embraced advanced technologies such as additive manufacturing (AM) to push the limits of these vehicles and maximize performance. The team has chosen to partner with 3D Systems to design and produce bespoke parts that not only will elevate BBI’s designs but to share with other exotic car manufacturers to elevate the sport.

During this session, Dmitriy Orlov, COO, BBI Autosport, will showcase some of the latest ongoing projects BBI has for the Pike’s Peak International Hill Climb. He will explore why AM was chosen to produce these unique parts and delve into the designs, materials, and 3D printing technologies that brought these parts to life.

Tuesday, June 25, 2024

2:30 PM | SME ZONE Theater
Manufacturing Tomorrow's Therapeutics: Innovations & Triumphs in Bioprinting: Presented by ARMI
Panelist: Katie Weimer, Vice President, Regenerative Medicine, 3D Systems

From tissues- and organs-on-a-chip, to regenerative acellular biomaterial implants, to cell therapy and pharmaceutical support, bioprinting technologies are increasingly proving to be an essential tool for creating and manufacturing a new wave of medical therapies and associated tools. Research advances from the previous 15-20 years are now increasingly progressing to commercial realities. This panel will delve into the subject by bringing together leaders from across medical 3D printing and Bioprinting. We will highlight and discuss recent scientific and commercial technology and product innovations and triumphs within the field and delve into how these recent triumphs create a foundation for a fast-growing industry. Come and hear what's next on the immediate horizon for bioprinting technologies and commercial efforts, as we touch not only technological developments and advances, but also dig into business, funding, regulatory challenges, and opportunities within the bioprinting therapeutics world. | This panel is brought to you by ARMI BioFabUSA.

Thursday, June 27, 2024

12:00 PM | Conference Room 409 A
Will Bioprinting Define the Next Era of 3D Printing?
Primary Presenter: Katie Weimer, Vice President, Regenerative Medicine, 3D Systems

More than 35 years ago, 3D printing was introduced as a prototyping tool. Since then, it has changed the way industries innovate, from industrial to healthcare and consumer goods. 3D printing technology, when combined with biology, is helping blaze the trail into the new frontier of bioprinting. Bioprinting allows the structuring of cells, growth factors, and/or biomaterials to fabricate biomedical constructs, often with the aim of replicating natural tissue characteristics. When combined with regenerative medicine (i.e., the treatment of disease by repairing or replacing damaged tissues or organs with the goal of restoring function while avoiding risk of rejection using a patient’s own cells), the goal is to fabricate functional tissues and organs.

The bioprinting application opportunity has the potential to change the future of humankind, and in the meantime, could reshape the 3D printing industry. The ability to manufacture functional human tissues and organs could: help solve the transplant crisis, create a new generation of personalized medicine, and improve the way drugs are tested and developed. Bioprinting could pave the way for true disruption in healthcare. There are still challenges with technically recreating the complex function of the human body, along with the more comprehensible challenges of accessibility, cost, standards, regulatory and bioethics.

Is this opportunity real? Will bioprinting define the next era of 3D printing? During this session, 3D Systems’ Vice President, Regenerative Medicine, Katie Weimer, will share the current state of bioprinting, underscore the trials and tribulations in the field, and speak to how many of the industry’s leading innovators are rising to the challenge to shape the future of bioprinting. Through showcasing promising applications, Katie will highlight how the fabrication of living tissues and organs can unlock the potential to drive research, develop new products, and improve patient lives.